Is Roku Stock Undervalued Now?
At roughly $89 a share, Roku (NASDAQ: ROKU) trades for barely…
Sell
35
PPH Quote, Financials, Valuation and Earnings
Last price:
$88.63
Seasonality move
:
-0.54%
Day range:
$87.57 - $88.53
52-week range:
$77.67 - $99.51
Dividend yield:
2.21%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
317K
Avg. volume:
443.8K
1-year change:
-4.95%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PPH
VanEck Pharmaceutical ETF
|
-- | -- | -- | -- | -- |
|
HART
NYLI Healthy Hearts ETF
|
-- | -- | -- | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | -- | -- | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | -- | -- | -- | -- |
|
VHT
Vanguard Health Care Index Fund ETF
|
-- | -- | -- | -- | -- |
|
XLV
Health Care Select Sector SPDR Fund
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PPH
VanEck Pharmaceutical ETF
|
$88.23 | -- | -- | -- | $0.61 | 2.21% | -- |
|
HART
NYLI Healthy Hearts ETF
|
$30.22 | -- | -- | -- | $0.17 | 1.55% | -- |
|
IXJ
iShares Global Healthcare ETF
|
$86.12 | -- | -- | -- | $0.76 | 1.6% | -- |
|
IYH
iShares US Healthcare ETF
|
$56.69 | -- | -- | -- | $0.17 | 1.35% | -- |
|
VHT
Vanguard Health Care Index Fund ETF
|
$249.12 | -- | -- | -- | $0.96 | 1.6% | -- |
|
XLV
Health Care Select Sector SPDR Fund
|
$135.19 | -- | -- | -- | $0.63 | 1.77% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PPH
VanEck Pharmaceutical ETF
|
-- | 0.308 | -- | -- |
|
HART
NYLI Healthy Hearts ETF
|
-- | 0.673 | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | 0.492 | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | 0.499 | -- | -- |
|
VHT
Vanguard Health Care Index Fund ETF
|
-- | 0.571 | -- | -- |
|
XLV
Health Care Select Sector SPDR Fund
|
-- | 0.461 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PPH
VanEck Pharmaceutical ETF
|
-- | -- | -- | -- | -- | -- |
|
HART
NYLI Healthy Hearts ETF
|
-- | -- | -- | -- | -- | -- |
|
IXJ
iShares Global Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
|
IYH
iShares US Healthcare ETF
|
-- | -- | -- | -- | -- | -- |
|
VHT
Vanguard Health Care Index Fund ETF
|
-- | -- | -- | -- | -- | -- |
|
XLV
Health Care Select Sector SPDR Fund
|
-- | -- | -- | -- | -- | -- |
VanEck Pharmaceutical ETF vs. Competitors
-
Which has Higher Returns PPH or HART?
NYLI Healthy Hearts ETF has a net margin of -- compared to VanEck Pharmaceutical ETF's net margin of --. VanEck Pharmaceutical ETF's return on equity of -- beat NYLI Healthy Hearts ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PPHVanEck Pharmaceutical ETF-- -- -- HARTNYLI Healthy Hearts ETF-- -- -- -
What do Analysts Say About PPH or HART?
VanEck Pharmaceutical ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand NYLI Healthy Hearts ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that VanEck Pharmaceutical ETF has higher upside potential than NYLI Healthy Hearts ETF, analysts believe VanEck Pharmaceutical ETF is more attractive than NYLI Healthy Hearts ETF.
Company Buy Ratings Hold Ratings Sell Ratings PPHVanEck Pharmaceutical ETF0 0 0 HARTNYLI Healthy Hearts ETF0 0 0 -
Is PPH or HART More Risky?
VanEck Pharmaceutical ETF has a beta of 0.588, which suggesting that the stock is 41.158% less volatile than S&P 500. In comparison NYLI Healthy Hearts ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock PPH or HART?
VanEck Pharmaceutical ETF has a quarterly dividend of $0.61 per share corresponding to a yield of 2.21%. NYLI Healthy Hearts ETF offers a yield of 1.55% to investors and pays a quarterly dividend of $0.17 per share. VanEck Pharmaceutical ETF pays -- of its earnings as a dividend. NYLI Healthy Hearts ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PPH or HART?
VanEck Pharmaceutical ETF quarterly revenues are --, which are smaller than NYLI Healthy Hearts ETF quarterly revenues of --. VanEck Pharmaceutical ETF's net income of -- is lower than NYLI Healthy Hearts ETF's net income of --. Notably, VanEck Pharmaceutical ETF's price-to-earnings ratio is -- while NYLI Healthy Hearts ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for VanEck Pharmaceutical ETF is -- versus -- for NYLI Healthy Hearts ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PPHVanEck Pharmaceutical ETF-- -- -- -- HARTNYLI Healthy Hearts ETF-- -- -- --
-
Which has Higher Returns PPH or IXJ?
iShares Global Healthcare ETF has a net margin of -- compared to VanEck Pharmaceutical ETF's net margin of --. VanEck Pharmaceutical ETF's return on equity of -- beat iShares Global Healthcare ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PPHVanEck Pharmaceutical ETF-- -- -- IXJiShares Global Healthcare ETF-- -- -- -
What do Analysts Say About PPH or IXJ?
VanEck Pharmaceutical ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Global Healthcare ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that VanEck Pharmaceutical ETF has higher upside potential than iShares Global Healthcare ETF, analysts believe VanEck Pharmaceutical ETF is more attractive than iShares Global Healthcare ETF.
Company Buy Ratings Hold Ratings Sell Ratings PPHVanEck Pharmaceutical ETF0 0 0 IXJiShares Global Healthcare ETF0 0 0 -
Is PPH or IXJ More Risky?
VanEck Pharmaceutical ETF has a beta of 0.588, which suggesting that the stock is 41.158% less volatile than S&P 500. In comparison iShares Global Healthcare ETF has a beta of 0.676, suggesting its less volatile than the S&P 500 by 32.448%.
-
Which is a Better Dividend Stock PPH or IXJ?
VanEck Pharmaceutical ETF has a quarterly dividend of $0.61 per share corresponding to a yield of 2.21%. iShares Global Healthcare ETF offers a yield of 1.6% to investors and pays a quarterly dividend of $0.76 per share. VanEck Pharmaceutical ETF pays -- of its earnings as a dividend. iShares Global Healthcare ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PPH or IXJ?
VanEck Pharmaceutical ETF quarterly revenues are --, which are smaller than iShares Global Healthcare ETF quarterly revenues of --. VanEck Pharmaceutical ETF's net income of -- is lower than iShares Global Healthcare ETF's net income of --. Notably, VanEck Pharmaceutical ETF's price-to-earnings ratio is -- while iShares Global Healthcare ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for VanEck Pharmaceutical ETF is -- versus -- for iShares Global Healthcare ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PPHVanEck Pharmaceutical ETF-- -- -- -- IXJiShares Global Healthcare ETF-- -- -- --
-
Which has Higher Returns PPH or IYH?
iShares US Healthcare ETF has a net margin of -- compared to VanEck Pharmaceutical ETF's net margin of --. VanEck Pharmaceutical ETF's return on equity of -- beat iShares US Healthcare ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PPHVanEck Pharmaceutical ETF-- -- -- IYHiShares US Healthcare ETF-- -- -- -
What do Analysts Say About PPH or IYH?
VanEck Pharmaceutical ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares US Healthcare ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that VanEck Pharmaceutical ETF has higher upside potential than iShares US Healthcare ETF, analysts believe VanEck Pharmaceutical ETF is more attractive than iShares US Healthcare ETF.
Company Buy Ratings Hold Ratings Sell Ratings PPHVanEck Pharmaceutical ETF0 0 0 IYHiShares US Healthcare ETF0 0 0 -
Is PPH or IYH More Risky?
VanEck Pharmaceutical ETF has a beta of 0.588, which suggesting that the stock is 41.158% less volatile than S&P 500. In comparison iShares US Healthcare ETF has a beta of 0.671, suggesting its less volatile than the S&P 500 by 32.885%.
-
Which is a Better Dividend Stock PPH or IYH?
VanEck Pharmaceutical ETF has a quarterly dividend of $0.61 per share corresponding to a yield of 2.21%. iShares US Healthcare ETF offers a yield of 1.35% to investors and pays a quarterly dividend of $0.17 per share. VanEck Pharmaceutical ETF pays -- of its earnings as a dividend. iShares US Healthcare ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PPH or IYH?
VanEck Pharmaceutical ETF quarterly revenues are --, which are smaller than iShares US Healthcare ETF quarterly revenues of --. VanEck Pharmaceutical ETF's net income of -- is lower than iShares US Healthcare ETF's net income of --. Notably, VanEck Pharmaceutical ETF's price-to-earnings ratio is -- while iShares US Healthcare ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for VanEck Pharmaceutical ETF is -- versus -- for iShares US Healthcare ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PPHVanEck Pharmaceutical ETF-- -- -- -- IYHiShares US Healthcare ETF-- -- -- --
-
Which has Higher Returns PPH or VHT?
Vanguard Health Care Index Fund ETF has a net margin of -- compared to VanEck Pharmaceutical ETF's net margin of --. VanEck Pharmaceutical ETF's return on equity of -- beat Vanguard Health Care Index Fund ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PPHVanEck Pharmaceutical ETF-- -- -- VHTVanguard Health Care Index Fund ETF-- -- -- -
What do Analysts Say About PPH or VHT?
VanEck Pharmaceutical ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Vanguard Health Care Index Fund ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that VanEck Pharmaceutical ETF has higher upside potential than Vanguard Health Care Index Fund ETF, analysts believe VanEck Pharmaceutical ETF is more attractive than Vanguard Health Care Index Fund ETF.
Company Buy Ratings Hold Ratings Sell Ratings PPHVanEck Pharmaceutical ETF0 0 0 VHTVanguard Health Care Index Fund ETF0 0 0 -
Is PPH or VHT More Risky?
VanEck Pharmaceutical ETF has a beta of 0.588, which suggesting that the stock is 41.158% less volatile than S&P 500. In comparison Vanguard Health Care Index Fund ETF has a beta of 0.690, suggesting its less volatile than the S&P 500 by 30.968%.
-
Which is a Better Dividend Stock PPH or VHT?
VanEck Pharmaceutical ETF has a quarterly dividend of $0.61 per share corresponding to a yield of 2.21%. Vanguard Health Care Index Fund ETF offers a yield of 1.6% to investors and pays a quarterly dividend of $0.96 per share. VanEck Pharmaceutical ETF pays -- of its earnings as a dividend. Vanguard Health Care Index Fund ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PPH or VHT?
VanEck Pharmaceutical ETF quarterly revenues are --, which are smaller than Vanguard Health Care Index Fund ETF quarterly revenues of --. VanEck Pharmaceutical ETF's net income of -- is lower than Vanguard Health Care Index Fund ETF's net income of --. Notably, VanEck Pharmaceutical ETF's price-to-earnings ratio is -- while Vanguard Health Care Index Fund ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for VanEck Pharmaceutical ETF is -- versus -- for Vanguard Health Care Index Fund ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PPHVanEck Pharmaceutical ETF-- -- -- -- VHTVanguard Health Care Index Fund ETF-- -- -- --
-
Which has Higher Returns PPH or XLV?
Health Care Select Sector SPDR Fund has a net margin of -- compared to VanEck Pharmaceutical ETF's net margin of --. VanEck Pharmaceutical ETF's return on equity of -- beat Health Care Select Sector SPDR Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PPHVanEck Pharmaceutical ETF-- -- -- XLVHealth Care Select Sector SPDR Fund-- -- -- -
What do Analysts Say About PPH or XLV?
VanEck Pharmaceutical ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Health Care Select Sector SPDR Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that VanEck Pharmaceutical ETF has higher upside potential than Health Care Select Sector SPDR Fund, analysts believe VanEck Pharmaceutical ETF is more attractive than Health Care Select Sector SPDR Fund.
Company Buy Ratings Hold Ratings Sell Ratings PPHVanEck Pharmaceutical ETF0 0 0 XLVHealth Care Select Sector SPDR Fund0 0 0 -
Is PPH or XLV More Risky?
VanEck Pharmaceutical ETF has a beta of 0.588, which suggesting that the stock is 41.158% less volatile than S&P 500. In comparison Health Care Select Sector SPDR Fund has a beta of 0.657, suggesting its less volatile than the S&P 500 by 34.272%.
-
Which is a Better Dividend Stock PPH or XLV?
VanEck Pharmaceutical ETF has a quarterly dividend of $0.61 per share corresponding to a yield of 2.21%. Health Care Select Sector SPDR Fund offers a yield of 1.77% to investors and pays a quarterly dividend of $0.63 per share. VanEck Pharmaceutical ETF pays -- of its earnings as a dividend. Health Care Select Sector SPDR Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PPH or XLV?
VanEck Pharmaceutical ETF quarterly revenues are --, which are smaller than Health Care Select Sector SPDR Fund quarterly revenues of --. VanEck Pharmaceutical ETF's net income of -- is lower than Health Care Select Sector SPDR Fund's net income of --. Notably, VanEck Pharmaceutical ETF's price-to-earnings ratio is -- while Health Care Select Sector SPDR Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for VanEck Pharmaceutical ETF is -- versus -- for Health Care Select Sector SPDR Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PPHVanEck Pharmaceutical ETF-- -- -- -- XLVHealth Care Select Sector SPDR Fund-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Microsoft Be a $5 Trillion Stock?
Microsoft’s market capitalization sits near $3.73 trillion today. To clear the…
Where Will C3.ai Stock Be in 1 Year?
C3 .ai (NYSE: AI) has been the poster child for “hype versus execution.”…
Stock Ideas
Buy
69
Is NVDA Stock a Buy?
Market Cap: $4T
P/E Ratio: 56x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 43x
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
58
INKT alert for Jul 14
MiNK Therapeutics [INKT] is down 20.04% over the past day.
Buy
51
NEGG alert for Jul 14
Newegg Commerce [NEGG] is down 17.32% over the past day.
Buy
68
ATRO alert for Jul 14
Astronics [ATRO] is down 2.08% over the past day.
